Marios K. Georgakis

7.6k total citations
100 papers, 3.2k citations indexed

About

Marios K. Georgakis is a scholar working on Genetics, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Marios K. Georgakis has authored 100 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 22 papers in Cardiology and Cardiovascular Medicine and 22 papers in Immunology. Recurrent topics in Marios K. Georgakis's work include Genetic Associations and Epidemiology (23 papers), Atherosclerosis and Cardiovascular Diseases (19 papers) and Dementia and Cognitive Impairment Research (12 papers). Marios K. Georgakis is often cited by papers focused on Genetic Associations and Epidemiology (23 papers), Atherosclerosis and Cardiovascular Diseases (19 papers) and Dementia and Cognitive Impairment Research (12 papers). Marios K. Georgakis collaborates with scholars based in Germany, United States and Greece. Marios K. Georgakis's co-authors include Martin Dichgans, Rainer Malik, Alkistis Skalkidou, Eleni Petridou, Dipender Gill, Christopher D. Anderson, Jürgen Bernhagen, Cathie Sudlow, Marco Duering and Joanna M. Wardlaw and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Marios K. Georgakis

97 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marios K. Georgakis Germany 32 678 594 568 435 408 100 3.2k
Christel Renoux Canada 30 331 0.5× 369 0.6× 842 1.5× 304 0.7× 681 1.7× 117 3.7k
Rainer Malik Germany 39 808 1.2× 1.1k 1.8× 664 1.2× 1.5k 3.5× 294 0.7× 90 4.8k
Barbara Kollerits Austria 32 693 1.0× 450 0.8× 522 0.9× 432 1.0× 384 0.9× 73 3.9k
Chuanhui Dong United States 33 973 1.4× 296 0.5× 913 1.6× 339 0.8× 173 0.4× 115 3.6k
Verena Zuber United Kingdom 31 394 0.6× 1.0k 1.7× 301 0.5× 784 1.8× 281 0.7× 77 2.9k
Christina Jern Sweden 33 1.1k 1.6× 215 0.4× 712 1.3× 553 1.3× 238 0.6× 143 3.3k
Michiko Yamada Japan 30 356 0.5× 178 0.3× 427 0.8× 695 1.6× 394 1.0× 152 3.7k
Iva Miljkovic United States 29 443 0.7× 312 0.5× 391 0.7× 620 1.4× 324 0.8× 112 3.2k
Ryan Langdon United Kingdom 13 761 1.1× 2.4k 4.0× 360 0.6× 1.5k 3.4× 398 1.0× 21 5.2k
Subrina Jesmin Japan 31 406 0.6× 169 0.3× 581 1.0× 671 1.5× 434 1.1× 148 2.8k

Countries citing papers authored by Marios K. Georgakis

Since Specialization
Citations

This map shows the geographic impact of Marios K. Georgakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marios K. Georgakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marios K. Georgakis more than expected).

Fields of papers citing papers by Marios K. Georgakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marios K. Georgakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marios K. Georgakis. The network helps show where Marios K. Georgakis may publish in the future.

Co-authorship network of co-authors of Marios K. Georgakis

This figure shows the co-authorship network connecting the top 25 collaborators of Marios K. Georgakis. A scholar is included among the top collaborators of Marios K. Georgakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marios K. Georgakis. Marios K. Georgakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lanyue, Rainer Malik, Tom G. Richardson, et al.. (2025). The genomic architecture of circulating cytokine levels points to drug targets for immune-related diseases. Communications Biology. 8(1). 34–34. 1 indexed citations
2.
Georgakis, Marios K., et al.. (2025). A Beneficial Role for Gluteofemoral Adipose Tissue in Cerebrovascular Disease. Neurology. 104(9). e213573–e213573. 2 indexed citations
3.
Anderson, Christopher D., et al.. (2024). Genetically proxied IL‐6 signaling and risk of Alzheimer's disease and lobar intracerebral hemorrhage: A drug target Mendelian randomization study. Alzheimer s & Dementia Translational Research & Clinical Interventions. 10(3).
4.
Mayerhofer, Ernst, Livia Parodi, Rainer Malik, et al.. (2023). Genetic Risk Score Improves Risk Stratification for Anticoagulation-Related Intracerebral Hemorrhage. Stroke. 54(3). 791–799. 5 indexed citations
5.
Mayerhofer, Ernst, Livia Parodi, Kaavya Narasimhalu, et al.. (2023). Genetic variation supports a causal role for valproate in prevention of ischemic stroke. International Journal of Stroke. 19(1). 84–93. 3 indexed citations
6.
Georgakis, Marios K., Antonis Argyris, Yi Zhang, et al.. (2022). Association of Pressure Wave Reflections With Left Ventricular Mass: a Systematic Review and Meta-Analysis. Hypertension. 80(3). e29–e42. 5 indexed citations
7.
Mayerhofer, Ernst, Rainer Malik, Livia Parodi, et al.. (2022). Genetically predicted on-statin LDL response is associated with higher intracerebral haemorrhage risk. Brain. 145(8). 2677–2686. 18 indexed citations
8.
Κόλλιας, Αναστάσιος, Panagiota Mitrou, Marios K. Georgakis, et al.. (2021). Does Sodium Intake Induce Systemic Inflammatory Response? A Systematic Review and Meta-Analysis of Randomized Studies in Humans. Nutrients. 13(8). 2632–2632. 9 indexed citations
9.
Katsanos, Aristeidis H., Lina Palaiodimou, Christopher Price, et al.. (2021). An Updated Meta-Analysis of RCTs of Colchicine for Stroke Prevention in Patients with Coronary Artery Disease. Journal of Clinical Medicine. 10(14). 3110–3110. 8 indexed citations
10.
Burgess, Stephen, Rainer Malik, Amy M. Mason, et al.. (2021). Dose–response relationship between genetically proxied average blood glucose levels and incident coronary heart disease in individuals without diabetes mellitus. Diabetologia. 64(4). 845–849. 16 indexed citations
11.
Malik, Rainer, Nathalie Beaufort, Benno Gesierich, et al.. (2021). Whole-exome sequencing reveals a role of HTRA1 and EGFL8 in brain white matter hyperintensities. Brain. 144(9). 2670–2682. 16 indexed citations
12.
Hyman, Matthew C., Michael G. Levin, Dipender Gill, et al.. (2021). Genetically Predicted Blood Pressure and Risk of Atrial Fibrillation. Hypertension. 77(2). 376–382. 19 indexed citations
13.
Malik, Rainer, Marios K. Georgakis, Marijana Vujković, et al.. (2021). Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses. Hypertension. 77(6). 2004–2013. 59 indexed citations
14.
Georgakis, Marios K., Rainer Malik, Stephen Burgess, & Martin Dichgans. (2021). Additive Effects of Genetic Interleukin‐6 Signaling Downregulation and Low‐Density Lipoprotein Cholesterol Lowering on Cardiovascular Disease: A 2×2 Factorial Mendelian Randomization Analysis. Journal of the American Heart Association. 11(1). e023277–e023277. 22 indexed citations
15.
Georgakis, Marios K., Dipender Gill, Alastair J.S. Webb, et al.. (2020). Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypes. Neurology. 95(4). e353–e361. 63 indexed citations
16.
Georgakis, Marios K., Marco Duering, Joanna M. Wardlaw, & Martin Dichgans. (2019). WMH and long-term outcomes in ischemic stroke. Neurology. 92(12). e1298–e1308. 143 indexed citations
17.
Gill, Dipender, Marios K. Georgakis, Fotios Koskeridis, et al.. (2019). Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects. Circulation. 140(4). 270–279. 89 indexed citations
18.
Gill, Dipender, Marios K. Georgakis, Michael Laffan, et al.. (2018). Genetically Determined FXI (Factor XI) Levels and Risk of Stroke. Stroke. 49(11). 2761–2763. 38 indexed citations
19.
Skalkidou, Alkistis, Theodoros Ν. Sergentanis, Marios K. Georgakis, et al.. (2017). Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility. Cochrane Database of Systematic Reviews. 2017(3). CD010931–CD010931. 26 indexed citations
20.
Georgakis, Marios K., Fotios C. Papadopoulos, Athanase D. Protogerou, et al.. (2016). Comorbidity of Cognitive Impairment and Late-Life Depression Increase Mortality. Journal of Geriatric Psychiatry and Neurology. 29(4). 195–204. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026